Skin necrosis caused by prilocaine: A case report

dc.contributor.buuauthorAytaç, Selçuk
dc.contributor.buuauthorEtöz, Abdullah
dc.contributor.buuauthorAkın, Selçuk
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Plastik ve Rekonstruktif Cerrahi Anabilim Dalı.tr_TR
dc.contributor.scopusid8956755700tr_TR
dc.contributor.scopusid8350090000tr_TR
dc.contributor.scopusid7005263372tr_TR
dc.date.accessioned2021-11-01T06:32:01Z
dc.date.available2021-11-01T06:32:01Z
dc.date.issued2005-03
dc.description.abstractPrilocaine (Citanest (R), AstraZeneca Pharmaceuticals, Wilmington, Del) is a commonly used agent in infiltrative anesthesia, and its adverse effects are well known. The authors report a full-thickness skin necrosis after using prilocaine as a local anesthetic that resulted in a flop closure. To the authors' knowledge, there have been no previously described cases of skin necrosis after use of the local anesthetic prilocaine. Possible adverse reactions to preservatives that are added to local anesthetics in pharmaceutical preparations may play a role in skin necrosis secondary to prilocaine usage. Multifactorial adverse effects may cause unexpected reactions with the use of prilocaine, a safe and frequently used pharmaceutical.en_US
dc.identifier.citationAytaç, S. vd. (2005). "Skin necrosis caused by prilocaine: A case report". Wounds-A Compendium of Clinical Research and Practice, 17(3), 58-61.en_US
dc.identifier.endpage61tr_TR
dc.identifier.issn1044-7946
dc.identifier.issn1943-2704
dc.identifier.issue3tr_TR
dc.identifier.scopus2-s2.0-17444406664tr_TR
dc.identifier.startpage58tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/22526
dc.identifier.volume17tr_TR
dc.identifier.wos000228052300003
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherH M P Communicationsen_US
dc.relation.journalWounds - A Compendium of Clinical Research and Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDermatologyen_US
dc.subjectSurgeryen_US
dc.subjectIntravenous regional anesthesiaen_US
dc.subject0.5-percent prilocaineen_US
dc.subjectLocal-anestheticsen_US
dc.subjectAdverse-reactionsen_US
dc.subjectArticaineen_US
dc.subjectCitanesten_US
dc.subject.emtreePreservativeen_US
dc.subject.emtreePrilocaineen_US
dc.subject.emtreeSultamicillinen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeDrug safetyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFrequency analysisen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInguinal regionen_US
dc.subject.emtreeInjection site reactionen_US
dc.subject.emtreeLocal anesthesiaen_US
dc.subject.emtreePruritusen_US
dc.subject.emtreeSkin flapen_US
dc.subject.emtreeSkin necrosisen_US
dc.subject.emtreeThicknessen_US
dc.subject.scopusLocal Anesthetic Agent; Hypersensitivity; Intradermal Testsen_US
dc.subject.wosDermatologyen_US
dc.subject.wosSurgeryen_US
dc.titleSkin necrosis caused by prilocaine: A case reporten_US
dc.typeArticle
dc.wos.quartileQ4 (Surgery)en_US

Files